Clinical

Study Design and Protocol Writing

In-depth expertise in creating successful trials

The integrity and consistency of the study protocol, including the chosen endpoints, are key to a clinical trial’s success. At Alira Health, we understand the importance of focused study design and are experts in producing comprehensive, well-written protocols.

With a focus on accuracy and consistency, our team works to ensure the study protocol makes sense both scientifically and logistically—a benefit to all partners and participants.

Support and guidance tailored to your needs

From the outset, our team works to understand all the complexities of the project, including indication-specific measures—an aspect that sets Alira Health apart among contract research organizations (CROs).

You can expect frequent communication and collaboration with our study design team as they tailor guidance to your specific business needs and trial requirements. Our study design and medical writing services include:
  • Protocols
  • Informed consent forms
  • Clinical study reports
  • FDA briefing documents
  • Investigator’s brochures
  • Abstracts, posters, and journal articles
  • Executive summaries for efficacy or safety
  • Patient narratives

Why choose Alira Health?

With Alira Health industry leading CRO as your partner, you will benefit from:

  • Exceptional customer service and site relations
  • In-depth expertise across the entire clinical trial process
  • Flexible and tailored service delivered by multidisciplinary and global teams
  • Frequent, transparent, and professional communication
  • Guarantee we will lead your study efficiently, safely, and successfully

Related News

Clinical
Publications October 7, 2021
Tips for Successful Sponsor and CRO Collaboration
The relationship between Sponsor and CRO is a critical aspect of an effective and timely clinical trial; when the relationship is transparent and smooth, the benefit is seen by all parties.
Clinical
News June 8, 2021
Alira Health Expands Its Global Clinical and Data Capabilities Through the Acquisition of CROS NT
We have acquired CROS NT, a data-driven Contract Research Organization (CRO) headquartered in Italy with offices across Europe and the United States. CROS NT provides high quality,(...)
Clinical
Multimedia June 4, 2021
Managing Relationships Between CROs and Clinical Trial Sites
Join us in this special episode of Alira Health’s Transformation Talks with a full cast of Alira Health experts.
Clinical
Publications April 6, 2021
Unlocking the Database Lock Process
In our latest whitepaper, in collaboration with CROS NT, Alira Health’s Vice President Clinical Development, Christopher Rao and Amanda Cross, US Country Manager Executive Director,(...)
Clinical Regulatory
News January 7, 2021
Alira Health Adds CMC Services through Acquisition of Chamow & Associates
We have acquired Chamow & Associates (www.chamowassociates.com), a California-based integrated CMC advisory firm. This acquisition brings expertise in biologics manufacturing, quality(...)
Clinical
Publications September 4, 2020
Clinical Trial Management – The Dharmic Approach
In this article, Sheryl Kelley, Alira Health’s Associate Director of Data Quality and Finance (and certified yoga instructor), writes about the connections between yoga, dharma, and(...)
Clinical
Publications July 1, 2020
Clinical Trials Trends: Remote Monitoring
The COVID-19 pandemic caused an urgent need to transition clinical trials from on-site to remote monitoring. Though the concept of remote monitoring existed before the pandemic, with(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.